Press releases
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
- Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
- Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests
- Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
- Dexcom Reports First Quarter 2023 Financial Results
- Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
- Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
- Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
- Dexcom Publishes Annual Sustainability Report
More ▼
Key statistics
As of last trade DEXCOM INC DRN (D1EX34:SAO) traded at 12.34, -4.34% below its 52-week high of 12.90, set on Dec 14, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | 12.25 |
Offer | 12.28 |
Previous close | 12.34 |
Average volume | 3.79k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 05 2023.
More ▼